Aspargo Labs On The Rise Of Liquid Oral Suspensions For Better Patient Adherence

 
• By Urtė Fultinavičiūtė

CEO Michael Demurjian discusses the importance of reformulated liquid oral suspension drugs, while outlining plans to launch a smart device that connects patients and doctors.

Pills and throat spray
(Shutterstock)

More from Leadership

More from C-Suite Speaks